Skip to main content

Sacituzumab govitecan User Reviews & Ratings

Brand names: Trodelvy

Sacituzumab govitecan has an average rating of 7.4 out of 10 from a total of 5 reviews on Drugs.com. 80% of reviewers reported a positive experience, while 20% reported a negative experience.

Condition Avg. Rating Reviews Compare
Breast Cancer
7.4
 5 reviews for Breast Cancer 82 medications

Write a review

  • Ibc...
  • Taken for less than 1 month
  • January 26, 2025

For Breast Cancer "Excellent response in my daughter’s breathing. She has stage 4 inflammatory breast cancer that has spread to her lungs. After just 24 hours of taking this chemotherapy, she is breathing without difficulty."

10 / 10
Was this helpful?YesNo
0 Report
  • Jan...
  • Taken for 1 to 6 months
  • January 19, 2024

Sacituzumab govitecan for Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"

8 / 10
Was this helpful?YesNo
4 Report
  • Ell...
  • February 5, 2024

Sacituzumab govitecan for Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."

8 / 10
Was this helpful?YesNo
3 Report
  • sil...
  • Taken for 6 months to 1 year
  • December 5, 2024

Sacituzumab govitecan for Breast Cancer "It helped to have good PET scans and to shrink tumors in my chest."

9 / 10
Was this helpful?YesNo
1 Report
  • Sta...
  • Taken for 1 to 6 months
  • April 24, 2024

Sacituzumab govitecan for Breast Cancer "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."

2 / 10
Was this helpful?YesNo
1 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.